Quercetin Administration Mitigated Oxidative Stress And The Alterations In Thioredoxin-1 Levels Caused By High Sucrose Intake In Rat Thoracic Aortas.

Quercetin, Oxidative Stress, and TRX 1 Modulation

Authors

DOI:

https://doi.org/10.24925/turjaf.v13i11.3321-3327.8028

Keywords:

High sucrose intake, Thioredoxin 1, Oxidative stress indicators, Flavonoid, Rat Thoracic Aorta

Abstract

Oxidative stress is considered a contributing factor to the rapid advancement of complications associated with metabolic syndrome. Additionally, thioredoxins are essential components required for the redox regulation of protein thiol groups. The objective of this study was to examine the roles of quercetin and thioredoxin-1 in the mechanisms that may mediate their therapeutic potential. Male Wistar rats were administered 32% sucrose in their drinking water over a 20-week period to induce metabolic syndrome. Following this induction, quercetin was given orally at a dose of 15 mg/kg/day. At the conclusion of the study, blood samples from each group were evaluated for lipid profiles and thioredoxin-1 protein levels. In addition, antioxidant enzyme activities, total oxidant and antioxidant status, nitric oxide metabolite concentrations, protein thiol levels, and thioredoxin-1 protein levels were assessed in aortic tissues. Rats exposed to high sucrose intake exhibited elevated serum lipid concentrations, malondialdehyde levels, total oxidant status, and thioredoxin-1 protein levels in the serum. These increases were significantly mitigated by quercetin treatment. Furthermore, sucrose consumption resulted in a notable reduction in antioxidant markers, including superoxide dismutase, glutathione peroxidase, catalase, total antioxidant status, and thioredoxin-1, within aortic tissue homogenates. Supplementation with quercetin effectively reversed these declines, restoring antioxidant parameters. Overall, the findings indicate that quercetin plays a protective role under oxidative stress by strengthening the body's antioxidant defense mechanisms, particularly through its regulatory effect on thioredoxin-1, a key antioxidant protein involved in maintaining cellular redox balance.

References

Ahmed, O. A. A., Hassan, N. A., Azhar, A. S., El-Mas, M. M., & El-Bassossy, H. M. (2021). A nanopharmaceutical formula of quercetin protects from cardiovascular complications associated with metabolic syndrome. Frontiers in Pharmacology, 12, 1–11. https://doi.org/10.3389/fphar.2021.696981

Ahmed, M. G., Mehmood, M. H., Mehdi, S., & Farrukh, M. (2023). Caryopteris odorata and its metabolite coumarin attenuate characteristic features of cardiometabolic syndrome in highrefined carbohydrate-high fatcholesterol-loaded feed-fed diet rats. Frontiers in Pharmacology, 14, 1097407. https://doi.org/10.3389/fphar.2023.1097407

Alvarez, C. M. M., Hernandez-Cruz, E. Y., & Pedraza-Chaverri, J. (2023). Oxidative stress in animal models of obesity caused by hypercaloric diets: A systematic review, Life Sciences, 331, 122019. https://doi.org/10.1016/j.lfs.2023.122019

Aminjan, H. H., Abtahi, S. R., Hazrati, E., Chamanara, M., Jalili, M., & Paknejad, B. (2019). Targeting of oxidative stress and inflammation through ROS/NFkappaB pathway in phosphine-induced hepatotoxicity mitigation. Life Sciences, 232, 116607. https://doi.org/10.1016/j.lfs.2019.116607

Bilginoğlu, A. (2019). Possible protective effect of quercetin against oxidative stress in liver from metabolic syndrome rats. Journal of Contemporary Medicine, 9(2), 00–00. https://doi.org/10.16899/jcm.575413

Chandimali, N., Bak, S. G., Park, E. H., Lim, H. J., Won, Y. S., Kim, E. K., Park, S. I., & Lee, S. J. (2025). Free radicals and their impact on health and antioxidant defenses: a review. Cell Death Discovery, 11, 19. https://doi.org/10.1038/s41420-024-02278-8

Chellian, J., Mak, K. K., Chellappan, D. K., Krishnappa, P., & Pichika, M. R. (2022). Quercetin and metformin synergistically reverse endothelial dysfunction in the isolated aorta of streptozotocin-nicotinamide- induced diabetic rats. Science Reports, 12, 21393. https://doi.org/10.1038/s41598-022-25739-5

Dagher, O., Mury, P., Thorin-Trescases, N., Noly, P. E., Thorin, E., & Carrier, M. (2021). Therapeutic Potential of Quercetin to Alleviate Endothelial Dysfunction in Age-Related Cardiovascular Diseases. Frontiers in Cardiovascular Medicine, 8, 658400. https://doi.org/10.3389/fcvm.2021.658400

Del Río-Solá, M. L., Losa-Rodríguez, R., Aguirre-Gervás, B., & Gonzalo-Benito, H. (2023). Impact of oxidative stress on the progression of carotid atherosclerosis. Angiología, 75(6), 349–361. https://dx.doi.org/10.20960/angiologia.00494

Dhanya, R. (2022). Quercetin for managing type 2 diabetes and its complications, an insight into multitarget therapy. Biomedicine & Pharmacotherapy, 146, 112560. https://doi.org/10.1016/j.biopha.2021.112560

Emerald, B. S., Mohsin, S., D’Souza, C., John, A., El-Hasasna, H., Ojha, S., Raza, H., al-Ramadi, B., & Adeghate, E. (2022). Diabetes Mellitus Alters the Immuno-Expression of Neuronal Nitric Oxide Synthase in the Rat Pancreas. International Journal of Molecular Sciences, 23, 4974. https://doi.org/10.3390/ijms23094974

Godoy, J. R., Pittrich, S., Slavic, S., Lillig, C. H., Hanschmann, E. M., & Erben, R. G. (2021). Thioredoxin 1 is upregulated in the bone and bone marrow following experimental myocardial infarction: evidence for a remote organ response. Histochemistry and Cell Biology, 155(1), 89–99. https://doi.org/10.1007/s00418-020-01939-w

Hutcheson, R., & Rocic, P. (2012). The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: The great exploration. Experimental Diabetes Research, 2012, 1–13. https://doi.org/10.1155/2012/271028

Kundumani-Sridharan, V., Subramani, J., & Das, K. C. (2015). Thioredoxin Activates MKK4-NFκB Pathway in a Redox-dependent Manner to Control Manganese Superoxide Dismutase Gene Expression in Endothelial Cells. Journal of Biological Chemistry. 290(28), 17505–19. https://doi.org/10.1074/jbc.M115.660365

Lu, J., Huang, Y., Zhang, Y., Xie, J., Guo, Q., Yang, H., Yang, Y., Chen, J., & Su, L. (2025). Quercetin ameliorates obesity and inflammation via microbial metabolite indole-3-propionic acid in high fat diet-induced obese mice. Frontiers in Nutrition, 12, 1574792. https://doi.org/10.3389/fnut.2025.1574792

Martinelli, I., Tomassoni, D., Michele, M., Roy, P., Cifani, C., Amenta, F., & Tayebati, S. K. (2020). Cardiovascular Changes Related to Metabolic Syndrome: Evidence in Obese Zucker Rats. International Journal of Molecular Sciences, 21, 2035. https://doi.org/10.3390/ijms21062035

Nyarko, K. (2024). Investigating the Antioxidant Properties of Quercetin. IntechOpen, Quercetin - Effects on Human Health. http://dx.doi.org/10.5772/intechopen.1004648

Oberacker, T., Kraft, L., Schanz, M., Latus, J., & Schricker, S. (2023). The Importance of Thioredoxin-1 in Health and Disease. Antioxidants, 12, 1078. https://doi.org/10.3390/antiox12051078

Palmieri, V. O., Coppola, B., Grattagliano, I., Casieri, V., Cardinale, G., Portincasa, P., Palasciano, G., & Di Serio, F. (2013) Oxidized LDL receptor 1 gene polymorphism in patients with metabolic syndrome. European Journal of Clinical Investigation, 43(1), 41–48. https://doi.org/10.1111/eci.12013

Papadea, P., Skipitari, M., Kalaitzopoulou, E., Varemmenou, A., Spiliopoulou, M., Papasotiriou, M., Papachristou, E., Goumenos, D., Onoufriou, A., Rosmaraki, E., Margiolaki, I. & Georgiou, C. D. (2023). Methods on LDL particle isolation, characterization, and component fractionation for the development of novel specific oxidized LDL status markers for atherosclerotic disease risk assessment. Frontiers in Medicine, 9, 1078492. https://doi.org/10.3389/fmed.2022.1078492

Pena-Orihuela, P., Camargo, A., Rangel-Zuniga, O. A., Perez-Martinez, P., Cruz-Teno, C., Delgado-Lista, J., & Roche, H. M. (2013). Antioxidant system response is modified by dietary fat in adipose tissue of metabolic syndrome patients. The Journal of Nutritional Biochemistry, 24(10), 1717–1723. https://doi.org/10.1016/j.jnutbio.2013.02.012

Raut, B. K., Upadhyaya, S. R., Bashyal, J., & Parajuli, N. (2023). In Silico and In Vitro Analyses to Repurpose Quercetin as a Human Pancreatic α-Amylase Inhibitor. American Chemical Society Omega, 8, 46, 43617–43631. https://doi.org/10.1021/acsomega.3c05082

Sharifi-Rad, M., Anil Kumar, N. V., Zucca, P., Varoni, E. M., Dini, L., Panzarini, E., Rajkovic, J., Tsouh Fokou, P. V., Azzini, E., Peluso, I., Prakash Mishra, A., Nigam, M., El Rayess, Y., Beyrouthy, M. E., Polito, L., Iriti, M., Martins, N., Martorell, M., Docea, A. O., Setzer, W. N., Calina, D., Cho, W. C., & Sharifi-Rad, J. (2020). Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases. Frontiers in Physiology, 11, 694. https://doi.org/10.3389/fphys.2020.00694

Sitia, R., & Rubartelli, X. A. (2020). Evolution, role in inflammation, and redox control of leaderless secretory proteins Journal of Biological Chemistry, 295, 22, 7799–7811. https://doi.org/10.1074/jbc.REV119.008907

Tabrizi, R., Tamtaji, O. R., Mirhosseini, N., Lankarani, K. B., Akbari, M., Heydari, S. T., Dadgostar, E., & Asemi, Z. (2020). The effects of quercetin supplementation on lipid profiles and inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials. Critical Reviews in Food Science and Nutrition, 60(11), 1855–1868. https://doi.org/10.1080/10408398.2019.1604491

Tan, Y., Cheong, M. S., & Cheang, W. S. (2022). Roles of Reactive Oxygen Species in Vascular Complications of Diabetes: Therapeutic Properties of Medicinal Plants and Food. Oxygen, 2(3), 246–268. https://doi.org/10.3390/oxygen2030018

Tretjakovs, P., Lurins, J., Svirskis, S., Gersone, G., Lurina, D., Rozenberga, U., Blumfelds, L., Bahs, G., Lejnieks, A., & Mackevics, V. (2021). Thioredoxin-1 and Correlations of the Plasma Cytokines Regarding Aortic Valve Stenosis Severity. Biomedicines, 9, 1041. https://doi.org/10.3390/biomedicines9081041

Vichova, T., Waldauf, P., Karpisek, M., Jarkovsky J., & Motovska, Z. (2021). Oxidative Stress Markers Thioredoxin 1 and 8-Isoprostane in Relation to Ischemic Time In Patients with ST- Elevations Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention. Polish Archives of Internal Medicine, 131(7-8). https://doi.org/10.20452/pamw.16057

Wang, M., Mao, Y., Wang, B., Wang, S., Lu, H., Ying, L., & Li, Y. (2020). Quercetin Improving Lipid Metabolism by Regulating Lipid Metabolism Pathway of Ileum Mucosa in Broilers. Oxidative Medicine and Cellular Longevity, 2020, 8686248(e1-17). https://doi.org/10.1155/2020/8686248

Yuan, D., Chu, J., Lin, H., Zhu, G., Qian, J., Yu, Y., Yao, T., Ping, F., Chen, F., & Liu, X. (2023). Mechanism of homocysteine-mediated endothelial injury and its consequences for atherosclerosis. Frontiers in Cardiovascular Medicine, 9, 1109445. https://doi.org/10.3389/fcvm.2022.1109445

Downloads

Published

23.10.2025

Issue

Section

Research Paper